Carlyle and Brighton Park agree to invest US$200 million in Indegene
Carlyle and Brighton Park agree to invest US$200 million in Indegene
Investment will accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions
BANGALORE, India and PRINCETON, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- The Carlyle Group (NASDAQ: CG), Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech solutions provider, today announced that Carlyle and Brighton Park Capital will acquire minority stakes in the company for US$200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company.